Your browser doesn't support javascript.
loading
Walking on common ground: a cross-disciplinary scoping review on the clinical utility of digital mobility outcomes.
Polhemus, Ashley; Ortiz, Laura Delgado; Brittain, Gavin; Chynkiamis, Nikolaos; Salis, Francesca; Gaßner, Heiko; Gross, Michaela; Kirk, Cameron; Rossanigo, Rachele; Taraldsen, Kristin; Balta, Diletta; Breuls, Sofie; Buttery, Sara; Cardenas, Gabriela; Endress, Christoph; Gugenhan, Julia; Keogh, Alison; Kluge, Felix; Koch, Sarah; Micó-Amigo, M Encarna; Nerz, Corinna; Sieber, Chloé; Williams, Parris; Bergquist, Ronny; Bosch de Basea, Magda; Buckley, Ellen; Hansen, Clint; Mikolaizak, A Stefanie; Schwickert, Lars; Scott, Kirsty; Stallforth, Sabine; van Uem, Janet; Vereijken, Beatrix; Cereatti, Andrea; Demeyer, Heleen; Hopkinson, Nicholas; Maetzler, Walter; Troosters, Thierry; Vogiatzis, Ioannis; Yarnall, Alison; Becker, Clemens; Garcia-Aymerich, Judith; Leocani, Letizia; Mazzà, Claudia; Rochester, Lynn; Sharrack, Basil; Frei, Anja; Puhan, Milo.
Affiliation
  • Polhemus A; Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, Switzerland. ashley.polhemus@uzh.ch.
  • Ortiz LD; ISGlobal, Barcelona, Spain.
  • Brittain G; Universitat Pompeu Fabra, Barcelona, Spain.
  • Chynkiamis N; CIBER Epidemiología y Salud Pública, Barcelona, Spain.
  • Salis F; Department of Neuroscience and Sheffield NIHR Translational Neuroscience BRC, Sheffield Teaching Hospitals NHS Foundation Trust & University of Sheffield, Sheffield, England.
  • Gaßner H; Department of Sport, Exercise and Rehabilitation, Faculty of Health and Life Sciences, Northumbria University Newcastle, Newcastle, UK.
  • Gross M; Department of Biomedical Sciences, University of Sassari, Sassari, Italy.
  • Kirk C; Department of Molecular Neurology, University Hospital Erlangen, Erlangen, Germany.
  • Rossanigo R; Department of Clinical Gerontology, Robert-Bosch-Hospital, Stuttgart, Germany.
  • Taraldsen K; Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK.
  • Balta D; Department of Biomedical Sciences, University of Sassari, Sassari, Italy.
  • Breuls S; Department of Neuromedicine and Movement Science, Norwegian University of Science and Technology, Trondheim, Norway.
  • Buttery S; Department of Electronics and Telecommunications, Politecnico di Torino, Torino, Italy.
  • Cardenas G; Department of Rehabilitation Sciences, KU Leuven, Leuven, Belgium.
  • Endress C; Department of Respiratory Diseases, University hospitals Leuven, Leuven, Belgium.
  • Gugenhan J; National Heart and Lung Institute, Imperial College London, London, UK.
  • Keogh A; ISGlobal, Barcelona, Spain.
  • Kluge F; Universitat Pompeu Fabra, Barcelona, Spain.
  • Koch S; CIBER Epidemiología y Salud Pública, Barcelona, Spain.
  • Micó-Amigo ME; Department of Clinical Gerontology, Robert-Bosch-Hospital, Stuttgart, Germany.
  • Nerz C; Department of Clinical Gerontology, Robert-Bosch-Hospital, Stuttgart, Germany.
  • Sieber C; Insight Centre for Data Analytics, University College Dublin, Dublin, Ireland.
  • Williams P; Department of Artificial Intelligence in Biomedical Engineering, Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU), Erlangen, Germany.
  • Bergquist R; ISGlobal, Barcelona, Spain.
  • Bosch de Basea M; Universitat Pompeu Fabra, Barcelona, Spain.
  • Buckley E; CIBER Epidemiología y Salud Pública, Barcelona, Spain.
  • Hansen C; Translational and Clinical Research Institute, Faculty of Medical Sciences, Newcastle University, Newcastle upon Tyne, UK.
  • Mikolaizak AS; Department of Clinical Gerontology, Robert-Bosch-Hospital, Stuttgart, Germany.
  • Schwickert L; Epidemiology, Biostatistics and Prevention Institute, University of Zurich, Zurich, Switzerland.
  • Scott K; National Heart and Lung Institute, Imperial College London, London, UK.
  • Stallforth S; Department of Neuromedicine and Movement Science, Norwegian University of Science and Technology, Trondheim, Norway.
  • van Uem J; ISGlobal, Barcelona, Spain.
  • Vereijken B; Universitat Pompeu Fabra, Barcelona, Spain.
  • Cereatti A; CIBER Epidemiología y Salud Pública, Barcelona, Spain.
  • Demeyer H; Insigneo Institute, Department of Mechanical Engineering, University of Sheffield, Sheffield, UK.
  • Hopkinson N; Department of Neurology, University Medical Center Schleswig-Holstein, Kiel, Germany.
  • Maetzler W; Department of Clinical Gerontology, Robert-Bosch-Hospital, Stuttgart, Germany.
  • Troosters T; Department of Clinical Gerontology, Robert-Bosch-Hospital, Stuttgart, Germany.
  • Vogiatzis I; Insigneo Institute, Department of Mechanical Engineering, University of Sheffield, Sheffield, UK.
  • Yarnall A; Department of Molecular Neurology, University Hospital Erlangen, Erlangen, Germany.
  • Becker C; Department of Neurology, University Medical Center Schleswig-Holstein, Kiel, Germany.
  • Garcia-Aymerich J; Department of Neuromedicine and Movement Science, Norwegian University of Science and Technology, Trondheim, Norway.
  • Leocani L; Department of Biomedical Sciences, University of Sassari, Sassari, Italy.
  • Mazzà C; Department of Electronics and Telecommunications, Politecnico di Torino, Torino, Italy.
  • Rochester L; Department of Rehabilitation Sciences, KU Leuven, Leuven, Belgium.
  • Sharrack B; Department of Respiratory Diseases, University hospitals Leuven, Leuven, Belgium.
  • Frei A; Department of Rehabilitation Sciences, Ghent University, Ghent, Belgium.
  • Puhan M; National Heart and Lung Institute, Imperial College London, London, UK.
NPJ Digit Med ; 4(1): 149, 2021 Oct 14.
Article in En | MEDLINE | ID: mdl-34650191
ABSTRACT
Physical mobility is essential to health, and patients often rate it as a high-priority clinical outcome. Digital mobility outcomes (DMOs), such as real-world gait speed or step count, show promise as clinical measures in many medical conditions. However, current research is nascent and fragmented by discipline. This scoping review maps existing evidence on the clinical utility of DMOs, identifying commonalities across traditional disciplinary divides. In November 2019, 11 databases were searched for records investigating the validity and responsiveness of 34 DMOs in four diverse medical conditions (Parkinson's disease, multiple sclerosis, chronic obstructive pulmonary disease, hip fracture). Searches yielded 19,672 unique records. After screening, 855 records representing 775 studies were included and charted in systematic maps. Studies frequently investigated gait speed (70.4% of studies), step length (30.7%), cadence (21.4%), and daily step count (20.7%). They studied differences between healthy and pathological gait (36.4%), associations between DMOs and clinical measures (48.8%) or outcomes (4.3%), and responsiveness to interventions (26.8%). Gait speed, step length, cadence, step time and step count exhibited consistent evidence of validity and responsiveness in multiple conditions, although the evidence was inconsistent or lacking for other DMOs. If DMOs are to be adopted as mainstream tools, further work is needed to establish their predictive validity, responsiveness, and ecological validity. Cross-disciplinary efforts to align methodology and validate DMOs may facilitate their adoption into clinical practice.

Full text: 1 Database: MEDLINE Type of study: Prognostic_studies / Systematic_reviews Language: En Year: 2021 Type: Article

Full text: 1 Database: MEDLINE Type of study: Prognostic_studies / Systematic_reviews Language: En Year: 2021 Type: Article